Covered recipient · General Payments record
LAKSHMAN RAO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,746.34
- Reported across 266 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $268.74 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $76.59 | 4 |
| GlaxoSmithKline, LLC. | $41.03 | 2 |
| Exact Sciences Corporation | $37.35 | 2 |
| Amgen Inc. | $29.43 | 2 |
| Nevro Corp. | $20.50 | 1 |
| Lilly USA, LLC | $19.47 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $17.10 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.78 | 1 |
| PFIZER INC. | $13.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $17.10 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147005055 | CMS |
| Amgen Inc. | $13.79 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117360872 | CMS |
| Amgen Inc. | $15.64 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117360874 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $13.78 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086187538 | CMS |
| Exact Sciences Corporation | $18.06 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114847733 | CMS |
| Exact Sciences Corporation | $19.29 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114847738 | CMS |
| GlaxoSmithKline, LLC. | $19.93 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116612724 | CMS |
| GlaxoSmithKline, LLC. | $21.10 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115886571 | CMS |
| Lilly USA, LLC | $19.47 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135144511 | CMS |
| Nevro Corp. | $20.50 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130762371 | CMS |
| Novo Nordisk Inc | $26.89 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096961137 | CMS |
| Novo Nordisk Inc | $16.49 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096910601 | CMS |
| Novo Nordisk Inc | $17.90 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097118878 | CMS |
| Novo Nordisk Inc | $15.31 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096937001 | CMS |
| PFIZER INC. | $13.49 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132094988 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.